Login

Traffic Data on SKY TG24 Business | Pasqualino Monti - CEO of ENAV 00:10:00

Share On Facebook Share On Twitter

Pasqualino Monti is Chief Executive Officer of ENAV since 28 April 2023.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Perion Network (PERI) CEO Doron Gerstel dismisses industry challenges in an interview with Oliver.
00:10:00
Exploring Financial Planning Administration: Roles, Qualifications, and Career Pathways
00:10:00
New partnership to build artificial intelligence factories and computers|Michael Dell, CHAIRMAN & CEO,Dell USA
00:10:00
focused on Applied Artificial Intelligence, and the first VC firm|Nicolai Wadstrom,Founder and General Partner,BootstrapLabs
00:10:00
Cofle SpA's Evolution and Future Prospects with CEO Walter Barbieri | Walter Barbieri, CEO, Cofle SpA.
00:10:00
Michael Gooch, Chairman and CEO of GFI Group Inc., leads a firm that offers competitive wholesale market brokerage services across global markets.
00:10:00
Odilon Almeida, CEO of ACI Worldwide, discusses the company's latest financial results and outlook for the coming months.
00:10:00
Mark Lasry Discusses Investment Insights and the Future of Avenue Capital and the Milwaukee Bucks | Mark Lasry, CEO , Avenue Capital Group.
00:10:00
I80 Gold CEO Euan Downey Discusses Market Trends and Company Strategy Amidst Industry Challenges
00:10:00
Essential Tips on Determining Your Capital Contribution to Your Company: Expert Insights from Katherine Taylor of Taylor Legal
00:10:00
Investor Perspectives: Insights from Marco on Mining Sector Trends
00:10:00
AdvTech Sees Continued Enrollment Growth Across Africa Amid High Demand for Quality Education | Roy Douglas, CEO, Advtech Ltd .

© 2017 - Neuhu+